INTRODUCTION
In the mid nineties two independent groups -looking for a new virus that could be an etiologic agent for the non-A-E hepatitis cases -isolated the Flaviviridae RNA virus, today, collectively referred to as GBV-C/ HGV (GBvirus-C/Hepatitis G Virus) 19, 39 . Due to its efficient parenteral transmission, the GBV-C/HGV has been found at high prevalence (14 -45%) in different groups worldwide exposed to transfused-blood andhemocomponents and in intravenous drug users 10, 38 .
Other illness-related groups have also been found to present high frequency of this virus: 3 to 55% in hemodialyzed patients 20, 45 , 15 to 61% in subjects who underwent organ transplant 31, 40 and 15 to 21% in patients with post-transfusional hepatitis 14, 43 .
Nonetheless, the GBV-C/HGV has not been confirmed to be the causal agent of the non-A-E hepatitis or of any other disease. Besides, this virus is widely present in healthy subjects, such as blood donors, with variable prevalence: 1 to 3% in Japan and USA 1, 34 and more than 10% in some African and other developing countries 4, 5 .
After all, the interest in the GBV-C/HGV has recently been restored -as a benevolent rather than a villain agent -for the allegedly association between its infection and a favorable clinical outcome from HIV-coinfected patients 44 . Yet disputable 32 , this possibility should be further investigated and data on GBV-C/HGV epidemiology, including genotype distribution, should be made available and may be valuable information.
The ubiquitous presence of this virus can be explained by the different ways of transmission it has been associated with: vertical 49, 50 , sexual 12, 32 and, possibly, blood-sucking insects 30 .
In Brazil, previous studies reported values for the GBV-C/HGV RNA prevalence in blood donors from 5.5 to 9.7% in the city of São Paulo 3, 17, 29 , and in Rio de Janeiro of about 8.2% 15 . Moreover, our study with a large sampling (1,039 subjects) of the general population of the city of São Paulo showed similar figure: 5.1% RNA positive samples 30 .
The GBV-C/HGV presents a genomic structure similar to the Hepatitis C virus (HCV): a single RNA molecule of about 10 Kb 16, 19 . Different genome regions were considered to study genetic variability in various populations throughout the world. In general, the coding regions -NS3 9, 28 , NS4b, NS5a and NS5b 13, 48 have not produced consistent phylogenetic analyses for a GBV-C/HGV classification. Conversely, other studies did lead to genotype classifications by sequencing (i) the noncoding regions -5'NCR 2, 18, 19, 22, 42 (ii) a portion of the coding region for the viral envelope 41 and (iii) the complete GBV-C/HGV genome 24, 41 .
Those studies on strains from various part of the world revealed five different genotypes of the HGV/GBV-C: type 1, predominantly found in Western Africa, 2 in Europe and America, 3 in Asia 21, 42 and, more recently, the subtypes 4 and 5 in Southeast Asia and South of Africa, respectively 23, 35, 36, 41, 46, 47 .
There are some data on HGV/GBV-C genotype distribution in Brazil.
GALLIAN et al. 8 have described two genotypes (1 and 2) in a rural population of the Northeast region. Yet in this region, PEREIRA et al. 27 have found, besides 1 and 2, the genotype 3 in patients co-infected with the hepatitis C virus (HCV).
In the work of FOCCACIA et al. 7 more than one thousand subjects were chosen upon specific criteria to allow an epidemiological survey in a representative sampling of the city of São Paulo. Those are invaluable sources for studying phylogenetics and genotype distribution, and no one has so far investigated such a population for these purposes; of those 1,039 samples, 53 turned out to be positive for GBV-C/HGV RNA 30 and are the subjects of the present work.
MATERIALS AND METHODS

Serum samples
The serum specimens were collected between February and May, 1996, in a previous cross-sectional study -conducted to estimate the prevalence of viral hepatitis infection in the city of São Paulo, Brazil 7 . Of those, RNA extraction and RT-PCR (see below) were carried out from 1,039 samples; the 53 positive samples described in our previous work 30 are the subjects of the present study.
The use of those samples for investigating HGV, among other viruses, was approved by the Committee of Ethical Research of the Institute of Infectology Emilio Ribas (São Paulo, SP); all subjects signed their informed consent.
RNA extraction and GBV-C/HGV reverse transcription and polymerase chain reaction (RT-PCR)
One hundred µl of serum were added to a 300 µl Trizol After amplification, 5 µl of the PCR product was used for electrophoresis analysis on a 2% agarose gel.
PCR control: in each experiment, along with a maximum number of 15 test samples, two water samples and one GBV-C RNA positive sample were included for checking reproducibility of GBV-C RNA extraction, reverse transcription and amplification.
Sequencing and genotyping
The 728 bp PCR product was purified with the QIAquick kit (QIAGEN, Germany), and directly sequenced in the ABI 310 and 377 sequencer with the ABI PRISM Big Dye Terminator Cycle Sequencing Ready Reaction (PE Applied Biosystems), following their protocol. The sequences were edited using the NAVIGATOR program (Applied Biosystems) and aligned with the sequences of the three main subtypes ( Fig. 1) with the CLUSTAL X program 11 . The phylogenetic analysis was carried out with the PHYLIP 3.5c program 6 . Bootstrap values were determined on 500 replicates of the sequence data with the SEQBOOT program. Phylogenetic reconstructions were generated by the NeighborJoining program 33 , and the distances were calculated by the maximum likelihood with the DNADIST program. The consensus tree was produced by the PAUP program (50% majority rule). 
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RESULTS
Of the 53 GBV-C/HGV positive samples subjected to PCR amplification, 24 yielded the NCR fragment (728 bp) at concentrations enough for automated sequencing, whereas nineteen produced insufficient material and 10 no detectable yield.
The phylogenetic analysis -carried out with standard strains -has revealed the genotypes 1, 2a and 2b, at 8.3% (2/24), 50% (12/24) and 41.7% (10/24), respectively (Fig. 1) .
DISCUSSION
Sequencing and phylogenetic analysis based on the 5' non-coding region (5'NCR) of nearly half (24/53) of the GBV-C/HGV positive isolates from a large sampling (1,039) of the city of São Paulo disclosed the following genotypes: 1 (8.3%), 2a (50%) and 2b (41.7%).
OLIVEIRA et al. 25 conducted a study with samples from blood donors of the Central Region of Brazil (Goiânia, capital of the State of Goiás), based on the same genome region of the GBV-C/HGV (5'NCR). They reported similar genotype distribution -2b (58.9%), 2a (23.5%) and 1 (17.6%) -as determined by restriction fragment length polymorphism 25 .
Studying the 5' untranslated region (5'UTR -another denomination for the non-coding region) of the GBV-C/HGV genome in isolates from a rural population from Bahia (Northeast of Brazil), GALLIAN et al. 8 have also found type 1 (6/35, 17.1%) and type 2 (29/35, 82.9%). Also in the Northeast region, but in patients co-infected with HCV, PEREIRA et al. 27 have found, besides type 1 (1a, 5.3%; 1b, 44.7%) and 2 (3.5%), type 3 (41.2%) and mixed infections (5.3%) with more than one of these genotypes.
In the neighbor country Argentina, among 21 GBV-C/HGV positive samples from human immunodeficiency virus (HIV)-infected intravenous drug users, the same genotypes were found: 1 (4.8%), 2a (52.4%) 2b (19%) and 3 (23.8%); whereas in eleven blood donors they found genotypes 2a (45.5%), 2b (45.5%) and 3 (9.1%) 26 .
In conclusion, genotypes 1 and 2 are present in southeastern-and northeastern-Brazilian populations, being type 2 relatively predominant in both cases. However, when studying samples from HCV-and HIVmixed infections, in Brazil and Argentina, genotype 3 appears at high frequencies (see above). The high prevalence of type 3 in more exposed groups might be a consequence of its later entrance in those populations through parenteral and/or sexual route. While types 1 and 2 would have entered the country with African and European people, respectively, since its earliest formation.
RESUMO
Distribuição dos genótipos do vírus GB-C (HGV) em indivíduos da cidade de São Paulo, Brasil
Há na literatura vários estudos filogenéticos e de distribuição de genótipos do chamado "Vírus GB-C" ou da "Hepatite G", mais conhecido pela dupla sigla "GBV-C/HGV". Ocorre que, em sua grande maioria, estas pesquisas foram realizadas com amostras de grupos ligados epidemiologicamente e não com indivíduos representativos da população geral. O presente estudo é uma continuação do primeiro trabalho no Brasil feito com este tipo de amostragem. Trata-se de análise filogenética e distribuição genotípica do GBV-C/HGV a partir de amostras isoladas dentre mais de 1.000 indivíduos da cidade de São Paulo. Para tanto, um fragmento de 728 pares de base da região 5' não-codificadora (5´NCR) do genoma viral, de 24 amostras, foi sequenciado e submetido à analise filogenética. Foram identificados os genótipos 1, 2a e 2b nas respectivas freqüências: 8,3% (2/24), 50% (12/24) e 41,7% (10/24). Concluindo, São Paulo apresenta uma distribuição de genótipos semelhante à publicada para outros estados e regiões do Brasil, endossando a idéia de que os tipos 1 e 2 teriam vindo com os africanos e europeus, respectivamente, e portanto estariam na população do país desde a sua formação.
